Cellular Origins

ENABLING PATIENT ACCESS TO CELL THERAPY AT SCALE Cellular Origins is enabling the manufacture of cell therapies at scale. Its Constellation platform uses mobile robotics and AI to automate and connect existing bioprocess tools. This eliminates the need to re-develop therapies for commercialisation. Cellular Origins' factory-led approach accelerates time-to-market, reduces risk, and supports the production of 100,000s of doses of transformative therapies.

Cellular Origins is enabling the manufacture of cell therapies at scale. 

With a flexible, scalable, factory-led approach, Cellular Origins has overcome the unique challenges of cell therapy manufacturing, unlocking access to the same advanced automation that has driven scale in logistics, automotive, and silicon fabrication industries.

Cellular Origins' platform, Constellation, combines mobile robotics and AI with proven bioprocess instruments, providing end-to-end manufacturing, eliminating therapy redevelopment, and speeding up clinical-to-commercial timelines.

Cellular Origins is trusted by market leaders such as J&J, Cytiva, Fresenius Kabi, Thermo Fisher Scientific, and Wilson Wolf. Constellation orchestrates seamless automation of existing workflows, reliably scaling manufacture to enable the production of 100,000s of doses of transformative therapies.

 

• Platform Technology
• Stem Cells/Regenerative Medicine
• ATMP